Functional Outcome of Hemorrhagic Transformation after Thrombolysis for Ischemic Stroke: A Prospective Study [0.03%]
溶栓治疗缺血性卒中后出血转化的功能预后：一项前瞻性研究
Mariam Annan,Marie Gaudron,Jean-Philippe Cottier et al.
Mariam Annan et al.
Background/aims: Hemorrhagic transformation (HT) is usually taken into account when symptomatic, but the role of asymptomatic HT is not well known. The aim of our study was to evaluate the link between HT after thrombolys...
Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study [0.03%]
基于静脉溶栓首次卒中长期生存的性别差异：Ebrictus研究
José Luis Clua-Espuny,Rosa Ripolles-Vicente,Teresa Forcadell-Arenas et al.
José Luis Clua-Espuny et al.
Background: A number of large trials have confirmed the benefits of thrombolysis in acute stroke, but there are gender differences. We sought to examine the relationship between sex and outcome after thrombolysis. ...
Periprocedural Risk of Stroke Is Elevated in Patients with End-Stage Renal Disease on Hemodialysis [0.03%]
终末期肾病血液透析患者的术前术后卒中风险较高
Laurel Cherian,James Conners,Shawna Cutting et al.
Laurel Cherian et al.
Objective: To describe the most common clinical factors and stroke etiologies in a case series of patients with end-stage renal disease on hemodialysis (ESRD/HD) with transient ischemic attack (TIA) or ischemic stroke (IS...
Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study [0.03%]
阵发性房颤的短暂性脑缺血发作患者的临床特征-多中心回顾分析
Yuka Hama,Toshiyuki Uehara,Tomoyuki Ohara et al.
Yuka Hama et al.
Background: Atrial fibrillation (AF) is an important risk factor for transient ischemic attack (TIA). However, little is known about the characteristics of TIA patients with AF. This study investigated the characteristics...
Observational Study
Cerebrovascular diseases extra. 2015 Jul 9;5(2):84-90. DOI:10.1159/000434689 2015
Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors [0.03%]
急性缺血性卒中的短门针时间及延迟因素的前瞻性识别
Sander M Van Schaik,Saskia Scott,Lonneke M L de Lau et al.
Sander M Van Schaik et al.
Background: The clinical benefit of intravenous thrombolysis (IVT) in acute ischemic stroke is time dependent. Several studies report a short median door-to-needle time (DNT; 20 min), mainly in large tertiary referral hos...
Endovascular Stroke Therapy Results Improve over Time: The 'Learning Curve' at a New Comprehensive Stoke Center [0.03%]
血管内卒中治疗的效果会随着时间的推移而改善：综合性卒中中心的学习曲线
Ethan A Benardete,Anil K Nair
Ethan A Benardete
Background: The requirements for a comprehensive stroke center (CSC) include the capability to perform endovascular stroke therapy (EST). EST is a complex process requiring early identification of appropriate patients and...
Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational Studies [0.03%]
花生四烯酸与脑缺血风险：观察性研究的系统评价
Mai Sakai,Saki Kakutani,Hisanori Tokuda et al.
Mai Sakai et al.
Background: Arachidonic acid (ARA) is a precursor of various lipid mediators. ARA metabolites such as thromboxane A2 cause platelet aggregation and vasoconstriction, thus may lead to atherosclerotic disease. It is unclear...
Endothelial Repair in Childhood Arterial Ischaemic Stroke with Cerebral Arteriopathy [0.03%]
儿童动脉病性脑卒中的内皮修复治疗
Despina Eleftheriou,Vijeya Ganesan,Ying Hong et al.
Despina Eleftheriou et al.
Background: We have previously shown that recurrent arterial ischaemic stroke (AIS) in children with cerebral arteriopathy is associated with increased circulating endothelial cells and endothelial microparticles, consist...
Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy [0.03%]
神经源性心肌病的蛛网膜下腔出血患者的血浆儿茶酚胺谱型分析
Michael Moussouttas,Elizabeth Mearns,Arthur Walters et al.
Michael Moussouttas et al.
Purpose: To investigate the connection between sympathetic function and neurogenic cardiomyopathy (NC), and to determine whether NC is mediated primarily by circulating adrenal epinephrine (EPI) or neuronally transmitted ...
Accidental Thrombolysis in a Stroke Patient Receiving Apixaban [0.03%]
阿哌沙班抗凝治疗的卒中患者意外接受组织型纤溶酶原激活物治疗
Felix Fluri,Michael Fleischer,Christoph Kleinschnitz
Felix Fluri